Vietnam Investment Review on MSN7d
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular CarcinomaLion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...
Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...
Israeli macrophage reprogramming immunotherapy company Enlivex Therapeutics (ENLV) announced “highly positive” clinical trial ...
According to the scientists, study participants had fewer days to recover from the illnesses when compared to the standard of ...
Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...
LimmaTech vaccinates first participants in phase 1 study of Staphylococcus aureus vaccine candidate LBT-SA7: Zurich Tuesday, February 18, 2025, 13:00 Hrs [IST] LimmaTech Biologics ...
As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...
Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing ...
The MAD cohort also saw adverse events such as hair loss and reductions in hemoglobin and neutrophil counts. These side ...
Drugs that can prevent or relieve migraine attacks are only effective for some people. Research is starting to untangle the ...
Veru Inc (VERU) advances its biopharmaceutical pipeline with promising clinical results while navigating financial hurdles ...
CARB-X awards LimmaTech US$6.5 million to advance clinical development of LBT-SA7 LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback